E Liu , Zhaofang Hang , Min Liu , Shouhong Mu , Weikai Han , Siqi Fan , Ziyu Shiney Shi , Qingwei Yue , Jinhao Sun
{"title":"Activation of Kv7.2/3 channels in the PL-NAcc circuit attenuates methamphetamine-associated contextual memory","authors":"E Liu , Zhaofang Hang , Min Liu , Shouhong Mu , Weikai Han , Siqi Fan , Ziyu Shiney Shi , Qingwei Yue , Jinhao Sun","doi":"10.1016/j.pnpbp.2025.111483","DOIUrl":null,"url":null,"abstract":"<div><div>Methamphetamine (METH), a powerful psychoactive substance, promotes the formation of the persistent drug-associated memories that have a significant contribution to relapse in drug addiction. The reward circuit of prelimbic cortical (PL) to the nucleus accumbens core (NAcc) is closely related to METH-associated contextual memory. To evaluate METH-associated contextual memory, we employed the conditioned place preference (CPP) paradigm. Inhibition of the PL-NAcc circuit by using chemogenetic strategies could significantly suppressed METH-induced CPP. The expression of Kv7.2 and Kv7.3 in the PL projecting to NAcc was reduced in METH-administered mice compared to control mice. In METH-administered mice, METH-induced CPP, neuronal excitability and synaptic plasticity in the PL-NAcc circuit could be attenuated by injecting the Kv7.2/3 agonist retigabine in PL. Furthermore, overexpression of Kv7.3 channels' in the PL-NAcc circuit attenuated METH-induced CPP. Our findings identify hat the PL-NAcc circuit could be the main reason in METH-associated contextual memory and provide evidence that Kv7.2/3′ activation in the PL may emerge as a novel therapeutic strategy for METH abuse.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"142 ","pages":"Article 111483"},"PeriodicalIF":3.9000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278584625002374","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Methamphetamine (METH), a powerful psychoactive substance, promotes the formation of the persistent drug-associated memories that have a significant contribution to relapse in drug addiction. The reward circuit of prelimbic cortical (PL) to the nucleus accumbens core (NAcc) is closely related to METH-associated contextual memory. To evaluate METH-associated contextual memory, we employed the conditioned place preference (CPP) paradigm. Inhibition of the PL-NAcc circuit by using chemogenetic strategies could significantly suppressed METH-induced CPP. The expression of Kv7.2 and Kv7.3 in the PL projecting to NAcc was reduced in METH-administered mice compared to control mice. In METH-administered mice, METH-induced CPP, neuronal excitability and synaptic plasticity in the PL-NAcc circuit could be attenuated by injecting the Kv7.2/3 agonist retigabine in PL. Furthermore, overexpression of Kv7.3 channels' in the PL-NAcc circuit attenuated METH-induced CPP. Our findings identify hat the PL-NAcc circuit could be the main reason in METH-associated contextual memory and provide evidence that Kv7.2/3′ activation in the PL may emerge as a novel therapeutic strategy for METH abuse.
期刊介绍:
Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject.
Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.